Dr. Marc C. Peden, MD

Dr. Peden practices at Retina Associates of Florida, P.A. in Tampa, Florida.

Dr. Peden's NPI, 1316028335, was assigned on October 17, 2006. Dr. Peden graduated from University Of Florida College Of Medicine in 2003. Dr. Peden holds Florida license ME96228.

Dr. Peden's primary practice is Retina Associates of Florida, P.A., at 602 S Macdill Ave, Tampa, FL 33609 in Hillsborough County. The practice phone is (813) 875-6373.

Dr. Peden's primary practice is Retina Associates of Florida, P.A. in Tampa, Florida. Dmand AI also links Dr. Peden to 1 group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Peden practices. Vendor and product names are available with a free account.

Ophthalmology is Dr. Peden's primary specialty in the NPI Registry, under taxonomy code 207W00000X. Dr. Peden is board certified in ophthalmology by the American Board of Ophthalmology. Dr. Peden is licensed in Florida.

Dmand AI lists age-related macular degeneration, cataract, cataract surgery with lens implant, glaucoma, laser destruction of retinal or choroid lesions, retinal detachment, retinal occlusion and secondary membranaous cataract surgery among the conditions Dr. Peden treats.

CMS data shows 62,825 Medicare services from Dr. Peden across 17 procedure codes in 2024, for 827 Medicare patients. Medicare paid $2,259,579 for them.

CMS counts 827 Medicare patients who saw Dr. Peden in 2024. The largest group is 75 to 84, with 327 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 2% are also on Medicaid. Their average risk score is 1.46, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Peden's median patient age at 70, with 56% women.

In 2024, Dr. Peden wrote 461 Medicare Part D claims for 137 patients. 61% of them were for generic drugs. CMS names the drug for 357 of them, across 9 drugs with 11 or more claims each, at $13,052 in total drug cost. In 2023, CMS named 396 claims across 11 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 95 out of 100 for Dr. Peden for performance year 2024, reported as part of a group. Dr. Peden accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 37 procedures of cataract surgery by Dr. Peden, more than 57% of the clinicians it reports for that procedure.

Dmand AI links 20 papers to Dr. Peden, published from 2009 to 2021. 2014 was the busiest year, with 4. The most frequent topics are Angiogenesis Inhibitors, Antibodies, Monoclonal and Antibodies, Monoclonal, Humanized. Dr. Peden's most frequent co-authors are Shalesh Kaushal, MD, PhD, Mark B. Sherwood, MD and Muhammad Tariq Bhatti, MD.

Dmand AI links Dr. Peden to 1 clinical trial.

CMS Open Payments shows 368 general payments to Dr. Peden from 29 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 52% of the total. Genentech, Inc. paid the most, $93,875.

Dr. Peden graduated from University Of Florida College Of Medicine in 2003.

Dr. Peden is in network with 17 carriers, including Aetna, Excellus BlueCross BlueShield and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 12. Check the plan with the practice before a visit.